Celyad Oncology SA
XBRU:CYAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
R
|
Randstad NV
F:RSH
|
NL |
|
Tubos Reunidos SA
MAD:TRG
|
ES |
|
B
|
Bertrandt AG
XBER:BDT
|
DE |
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
KR |
|
Highland Copper Company Inc
XTSX:HI
|
CA |
|
Ateme SA
PAR:ATEME
|
FR |
|
B
|
B2Gold Corp
AMEX:BTG
|
CA |
|
A
|
Adidas AG
XBER:ADS
|
DE |
|
Nestle SA
SIX:NESN
|
CH |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
US |
|
China Resources Cement Holdings Ltd
HKEX:1313
|
HK |
Intrinsic Value
The intrinsic value for Celyad Oncology SA (CYAD) under the Base Case is hidden
EUR.
Compared with the current market price of 0.272 EUR, the stock appears hidden
.
CYAD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CYAD usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Celyad Oncology SA.
The intrinsic value for Celyad Oncology SA (CYAD) under the Base Case is hidden EUR.
Compared with the current market price of 0.272 EUR, the stock appears hidden.
